TET2 deficiency reprograms the germinal center B cell epigenome and silences genes linked to lymphomagenesis
Wojciech Rosikiewicz, Xiaowen Chen, Pilar M Dominguez, Hussein Ghamlouch, Said Aoufouchi, Olivier A Bernard, Ari Melnick, Sheng Li
Science Advances | AMER ASSOC ADVANCEMENT SCIENCE | Published : 2020
Awarded by Follicular Lymphoma Consortium
Awarded by National Institute of General Medical Sciences of the NIH
Awarded by Jackson Laboratory Director's Innovation Fund
Awarded by National Cancer Institute of the NIH
A.M. is funded by R35 CA220499, LLS TRP 6572-19, LLS SCOR 7012-16, the Follicular Lymphoma Consortium, Samuel Waxman Cancer Research Foundation, and the Chemotherapy Foundation. S.L. is supported by the National Institute of General Medical Sciences of the NIH under award number R35 GM133562, Leukemia Research Foundation New Investigator Grant, The Jackson Laboratory Director's Innovation Fund 19000-17-31, and The Jackson Laboratory Cancer Center New Investigator Award. Research reported in this publication was partially supported by the National Cancer Institute of the NIH under award number P30 CA034196. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. P.M.D. was supported by a Lymphoma Research Foundation Postdoctoral Fellowship.